RE:RE:IS This True?Here's how Keppner and Borkowski lied back in March 2016 when responding to a question about Donnatel's declining scripts:
Martin Landry
Okay that's fair. And the next question on Donnatal, looking at the IMS data, it feels like the scripts have declined a little bit in Q1 or at a more rapid pace than what we've seen historically. Just wondering if you could comment on that? Is there anything that's impacting Donnatal in Q1?
Wayne Kreppner
Hey Martin its Wayne. I would just say that from a Donnatal perspective, you have to recall that as I mentioned we have repositioned the sale force, so we actually took the sales force out of the field for about two weeks while we launched at new National Sales Meeting as the resources and retargeted some of those sales personnel.
And so we saw a little bit of softness around that period, because obviously this is just a mostly sensitive product that was going to remind our detail. So seeing the doctors on a repeated basis is important and so on that basis, we saw a little bit of softness, but we are not fully staffed in the new sales force and the sales efforts as of the end of February. So we expect that to take up as we go forward this year.
Edward J. Borkowski
We really think to add is we have a lot of confidence in that product, we've always had confidence in that product and we wouldn't be increasing the size of the field force if we didn't have that confidence. So I was going to ask you, be a little bit patient and that field force take effect.
...